Skip to main navigation Skip to search Skip to main content

The control of the consumer risk in the Ames assay

Markus Neuhäuser*, Ludwig A. Hothorn

*Corresponding author for this work

Research output: Contribution to journalArticleResearchpeer review

Abstract

Preclinical tests in genetic toxicology represent safety studies. Therefore, the primary concern in the evaluation of Ames test data is the control of the consumer risk, that is, the risk of erroneously concluding safety. Hence, an equivalence test procedure is adequate. This approach is presented beside the two-fold rule and classical tests for differences with respect to an order restricted alternative.

Original languageEnglish
Pages (from-to)363-367
Number of pages5
JournalDrug Information Journal
Volume31
Issue number2
DOIs
Publication statusPublished - 30 Dec 1997

UN Sustainable Development Goals (SDGs)

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Ames assay
  • Consumer risk
  • Difference approach
  • Equivalence test procedures for ordered many-to-one designs

ASJC Scopus subject areas

  • Pharmacology (nursing)
  • Drug guides
  • Public Health, Environmental and Occupational Health
  • Pharmacology (medical)

Cite this